Europe Urinary Catheters Market Size, Share & COVID-19 Impact Analysis, By Product (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia, Surgery, and Others), By Gender (Male and Female), By End-user (Hospitals, Age Care Centers, and Others), and Regional Forecast, 2023-2030

The Europe urinary catheters market size was valued at USD 1.32 billion in 2022. The market is projected to grow from USD 1.41 billion in 2023 to USD 2.32 billion by 2030, exhibiting a CAGR of 7.4% during the forecast period.

According to the National Health Service (NHS), urinary catheterization is used to drain the bladder and collect urine in individuals with difficulty urinating naturally through flexible tubes called urinary catheters. Some conditions, including prostate enlargement (also known as benign prostatic hyperplasia), bladder cancer, and urinary incontinence, obstruct the urine flow and require catheterization to pass urine. Moreover, these products are used in emptying the bladder before and after surgery and aid in performing certain tests. A rise in the prevalence of various urinary disorders among the population and an increase in surgical procedures are a few factors responsible for the Europe urinary catheters market growth.

Furthermore, as per various regional studies, it has been demonstrated that aging increases the risk of developing various bladder-associated problems among the population, such as urine retention, urine leakage, benign prostate hyperplasia, and others. According to Eurostat 2022 data, approximately 21.1% of the European population were aged 65 and above. The statistics also revealed that the median age of Europe’s population is increasing, half of the population in Europe was older than 44.4 years in 2022. Thus, the growing burden of the aging population in the region is one of the significant factors contributing to the growth of the market.

COVID-19 IMPACT

Reduction in the Volume of Urological Surgeries amid the COVID-19 Pandemic Hampered the Market Growth

The COVID-19 pandemic slowed down the market in 2020 due to a multitude of factors. Some factors include the reduction in patient visits to hospitals, disruptions in demand and supply chain due to the imposition of logistical restrictions across borders, and a temporary halt in various urological surgeries during the pandemic.

Additionally, as per the statistics published by the Organization for Economic Co-operation and Development (OECD), there was a steep decline in the various urological surgical procedures in many European countries.

• For instance, the number of transurethral prostatectomy surgeries decreased by 25% in 2020 compared to 2019 in France, Italy, and the U.K., some of the major countries in the region.

However, due to the resumption of normal healthcare activities in Europe due to ease in COVID-19 restrictions, the market regained normalcy by the end of 2021.

From 2022 onwards, the catheters market witnessed considerable growth owing to the launch of new products, an increase in strategic business activities among the key players, and a sustained increase in the prevalence of urinary diseases and surgeries.

LATEST TRENDS

Shifting Focus to Develop Advanced Products is Creating Growth Opportunities in the Market

Over the past few years, there has been a rising concern about Catheter-associated Urinary Tract Infections (CAUTI) among patients for an extended duration. To reduce the infections acquired owing to CAUTI, many researchers and companies are trying to develop innovative products with antimicrobial properties. Also, the government agencies' increased funds to support the development of these products with reduced infection rates provide opportunities in the market.

• For instance, in September 2019, the EU funded to the NANOELAST project to develop next-generation catheters that prevent infections.

Such initiatives made by manufacturers and national organizations will increase the adoption of these advanced products with a reduced risk of infection in the forthcoming years.

DRIVING FACTORS

Increasing Prevalence of Urinary Incontinence to Propel the Market Growth

Urinary incontinence is one of the growing concerns among the population across the globe. In Europe, urinary incontinence is considered a significant health problem. According to the World Health Organization (WHO), old age is characterized by developing several complex health issues, generally known as geriatric syndromes. Such syndromes are the consequence of many factors, including urinary incontinence and Benign Prostate Hyperplasia (BPH).

• In 2021, the European Association of Urology published the latest survey stating that urinary incontinence affects about 10%-20% of the European population.


• In addition, according to a 2021 study published in BioMed Central Ltd, urinary incontinence is more prevalent among older women and is about 37% in European countries.

Moreover, there are various products, such as absorbent pads, external collection devices, urinary catheters, penile clamps for men, and intravaginal devices for women, as mentioned by the European urinary incontinence management guidelines. However, the usage of these products has increased considerably in recent years, thereby propelling the market growth.

• According to an article published in the NCBI (National Center for Biotechnology Information) in 2021, Clean Intermittent Catheterization (CIC) users increased from 14,258 in 1997 to 45,909 in 2018. The CIC users nearly tripled from 92 users to 267 users per 100,000 persons.

Rising Number of Surgical Procedures to Augment the Market Growth

Globally, approximately 310 million major surgeries are performed annually, with 40-50 million in the U.S. and about 20 million in Europe. An increase in the number of surgeries will significantly increase the demand for these products, as these are generally used in patients undergoing surgeries to prevent urine incontinence or urine retention in an anesthetized patient. Furthermore, urinary catheters facilitate the output urine measurement. During and after surgeries, the output urine measurement is an indirect marker of the patient’s renal, cardiovascular, and fluid status.

• According to the U.K. Health Security Agency statistics published in 2021, about 31,644 (spinal surgeries), 1,739 (abdominal hysterectomies), 1,184 (bile duct, liver, or pancreatic surgeries), among others were performed in England from 2016 to 2021. Thus, the increased number of surgeries drives the adoption of these products, thereby augmenting the market growth.

RESTRAINING FACTORS

Rising Number of Catheter-Associated Urinary Tract Infections among Patients to Hinder the Market Growth

The rising concern associated while using urinary catheters is catheter-associated urinary infections is one of the substantial hindrances to the market growth. The infection caused by urinary catheters can lead to severe complications such as endocarditis and sepsis in patients with extended hospital stays. CAUTIs are the most common risk with indwelling catheters and are reported as Hospital-acquired Infections (HAI). According to the International Society for Infectious Diseases, the frequency of CAUTI is 19.6% in Europe.

• According to the 2019 European Centre for Disease Prevention and Control report, about 2% of the patients who stayed in ICUs acquired HAI with Urinary Tract Infection (UTI), and almost 98% of all the UTI episodes among the ICU-admitted patients were related to urinary catheters. A surge in such urinary catheter-associated complications is likely to hinder the market growth.

SEGMENTATION

By Product Analysis

Intermittent Catheters Segment Dominated the Market due to Increasing Adoption of these Products due to Various Benefits

Based on product, the Europe market can be segmented into indwelling catheters, intermittent catheters, and external catheters.

The intermittent catheters segment dominated the market share in 2022 due to the shift in homecare treatment among the patient population, various benefits associated with intermittent catheters, and an increase in the launch of advanced and more discreet intermittent catheters in the market. In addition, the key players developing eco-friendly intermittent catheters and growing strategic partnerships to introduce new intermittent catheters are some factors bolstering the sales of the intermittent catheters, resulting in the segment’s dominance in the Europe market.

Indwelling catheters is one of the fastest-growing segments and is expected to grow with significant CAGR. Indwelling catheters are most commonly used in hospital and clinical settings during surgeries. Thus, rising surgeries and hospital admission is expected to increase the demand for indwelling catheters in the upcoming years. Furthermore, the growing aging population with urinary diseases and the need for catheterization for a longer duration contribute to the segment’s market growth during the forecast period.

The external catheters segment is estimated to grow at a lower CAGR due to limited product offerings. Other factors include dislodgement and leakage, scarring of penile tissue, and skin irritation, contributing to its slow growth during the forecast period.

By Application Analysis

Urinary Incontinence Segment Dominated the Market Due to Rising Prevalence of the Condition in the European Countries

Based on application, the market is segmented into urinary incontinence, Benign Prostatic Hyperplasia (BPH), surgery, and others.

The urinary incontinence segment is driven by the increased prevalence of the condition among the European population. The urinary incontinence segment occupied the largest market share in 2022. According to the NHS estimates, an estimated 3 million to 6 million people in the U.K. suffer from urinary incontinence. Similar trends are observed in the other major countries in the region, which is expected to increase the adoption of these products, thus, bolstering the demand amongst the urinary incontinent patient population.

The surgery segment is expected to be the second leading segment and will grow faster than other segments in the upcoming years. The segment's growth is driven by increased surgeries performed annually in the region.

In addition, the BPH segment held a considerable market share in 2021 due to the rise in the male geriatric population prone to developing prostate enlargement. For instance, according to the study published in the National Library of Medicine in 2022, the mortality due to BPH has increased considerably with age. Transurethral Resection of the Prostate (TURP) was the most common operation type for lower urinary tract disorders across all age groups.

The others segment is expected to grow at a modest CAGR during the forecast period owing to the increase of various other urinary diseases leading to complexities, such as urine retention and urine leakage among the patients.

By Gender Analysis

Increased Adoption Rate of Urinary Catheters among the Male Population is Projected to Drive the Segment

Based on gender, the market is segmented into male and female. The male segment accounted for the highest market share in 2022 and is projected to grow at a fastest CAGR over the forecast period, owing to the rising prevalence of urological diseases such as benign prostate hyperplasia and prostate cancer among the European population. According to GLOBOCAN, in Europe, there were approximately 20.2% of new prostate cancer cases reported from all cancers. Moreover, the availability of less invasive or non-invasive types of urinary catheters, such as external (condom) catheters, increases the adoption rate among men.

On the contrary, the female segment exhibited a low market share in 2022 and is also expected to grow at a low CAGR during the forecast period. The availability of various alternative products for managing urine leakage among the target population is limiting the segment growth.

By End-user Analysis

Increase in the Number of Surgeries is Projected to Drive the Hospital Segment Market

Based on end-user, the market is classified into hospitals, age care centers, and others.

The hospital segment accounted for the highest revenue in the Europe market in 2022, owing to the increase in hospitalization for surgeries. The segment growth is driven by the rise in various urological disorders requiring surgeries and hospital stays. Furthermore, increasing hospital admissions for surgeries associated with injuries and chronic disorders where a patient's mobility is confined also drives the segment’s market growth.

The age care centers segment is projected to grow at a noteworthy CAGR during the forecast period. Despite an increase in admission to hospitals, there is a significant increase in admission in age care centers in the region due to an increasing burden of the aging population. According to the Government of the U.K.’s Care Homes Analysis (2022), approximately 400,000 older people live in care homes in the U.K., with the majority being above 80 years old and female. In addition, as per the reports of the European Association of Urology Nurses in collaboration with the European Network for Safer Healthcare and Health First Europe, an estimated 5% of elderly patients in homecare in Europe were on urinary catheters.

Furthermore, the other segment is expected to exhibit considerable market growth during the forecast period due to the shift in patient care from hospitals to homecare settings.

REGIONAL INSIGHTS

On the basis of region, the Europe market is segmented into Germany, France, the U.K., Italy, Spain, the Netherlands, Sweden, Switzerland, Poland, Ukraine, Portugal, Rest of Nordic, and Rest of Europe.

Germany generated a revenue of USD 0.33 billion in 2022 and is expected to dominate the market throughout the study period. The growing prevalence of patients suffering from urinary diseases, the geriatric population, and the number of surgeries are some of the factors anticipated to boost the market growth in Germany. For instance, as per a 2022 NCBI article, the prevalence of urolithiasis is about 5% among the German population. The high prevalence of urolithiasis contributes to the market growth, as untreated bladder and kidney stones lead to urine retention and require urinary catheterization.

Italy is projected to be the second most prominent market in terms of revenue by 2030. The rising prevalence of urinary incontinence, growing burden of urological cancers, and increasing aging population bolstered the country's market growth.

Moreover, France's urinary catheter market is anticipated to expand at a higher CAGR owing to growth factors such as enlarged prostate complications, a rise in pregnancy and childbirth, and an increase in surgical volumes in the country. For instance, according to the 2022 statistics of the World Bank, France has the highest birth rate of 11 per 1,000 people among the other EU 5 countries. Women's bladder weakens after childbirth, making them prone to urinary incontinence, thus increasing the demand for these catheters.

On the other hand, Spain accounted for a comparatively less market share than other EU 5 countries in the year 2022. The presence of a few players in the market and stigma amongst the population suffering from urinary incontinence is leading to slower growth in the country.

The market in Sweden and Ukraine is projected to grow rapidly due to the rising target population and regional companies focusing on developing and launching new, innovative catheters in the market.

Portugal, Netherlands, and Rest of Nordic countries are anticipated to register a moderate growth during the forecast period.

KEY INDUSTRY PLAYERS

Coloplast A/S Dominated the Market Owing to its Robust Product Portfolio

The market is consolidated in terms of the competitive landscape, with multinational companies holding a significant market share. Coloplast A/S has a top market position due to its robust product portfolio, comprehensive and well-established presence in Europe, and recent product launches. In April 2022, Coloplast A/S announced the launch of the SpeediCath Flex Set, an all-in-one solution with a soft catheter comprising triple action coating technology in markets between 2022 and 2023. The above-mentioned factors and the strong product sales in the region account for the company’s dominance in the market.

ConvaTec Group Plc is also one of the key players in the Europe market. The company indulges in various market expansion strategies to hold its position. In September 2019, the company acquired Southlake Medical Supplies, an independent provider of catheter-related supplies.

Other prominent players in the market include B. Braun Melsungen AG, Teleflex Incorporated, Hollister Incorporated, BACTIGUARD AB, and others. The growing focus of companies on various business activities and launches of new products is propelling market growth.

• For instance, in December 2020, BACTIGUARD AB collaborated with Libera Medica S.L. to distribute its infection-prevention products for urinary tract, bloodstream, and others in Spain.

LIST OF KEY COMPANIES PROFILED:

• Coloplast A/S (Denmark)


• B. Braun Melsungen AG (Germany)


• Hollister Incorporated (U.S.)


• Medline Industries, LP (U.S.)


• Clinisupplies Ltd.  (U.K.)


• Boston Scientific Corporation (U.S.)


• Convatec Group PLC (U.K.)


• Teleflex Incorporated (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• April 2023: Wellspect HealthCare (Dentsply Sirona) introduced the use of bioplastic in a female urinary catheter, “LoFric Elle.” It replaces conventional fossil-based raw materials and reduces the carbon footprint by 55%.


• January 2023: Bactiguard announced that it received its first (Medical Device Regulations 2017/745) product approval for latex BIP Foley Catheter, which is an indwelling urinary catheter.


• September 2022: Convatec Group PLC launched GentleCath Air, an intermittent catheter for men.


• April 2022: Coloplast A/S enhanced customer engagement using the user service program “Coloplast Care” by Oracle. This personalized, interactive service program was designed to help improve the users’ quality of life and condition management experience.


• April 2020: BACTIGUARD AB commercially launched the BIP Foley Temp Sensor, an indwelling catheter designed to prevent infection and allow temperature surveillances in patients.

REPORT COVERAGE

The market report provides qualitative and quantitative insights on the Europe market and a detailed analysis of Europe market size & growth rate for all possible segments in the market. Along with this, the report provides The market overview and an elaborative analysis of the regional market dynamics and competitive landscape. Various key insights presented in the report are the prevalence of obesity – for key countries/regions, new product launches, key recent industry developments – mergers, acquisitions, and partnerships, pipeline analysis, impact of COVID-19 on the Europe market and Europe urinary catheters market trends.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 7.4% from 2023 to 2030
Unit	Value (USD billion)
Segmentation	By Product, Application, Gender, End-user, and Geography
By Product	Indwelling Catheters Intermittent Catheters External Catheters
By Application	Urinary Incontinence Benign Prostatic Hyperplasia (BPH) Surgery Others
By Gender	Male Female
By End-user	Hospitals Age Care Centers Others
By Geography	U.K. (By Product, By Application, By Gender, By End-User) Germany (By Product, By Application, By Gender, By End-User) France (By Product, By Application, By Gender, By End-User) Italy (By Product, By Application, By Gender, By End-User) Spain (By Product, By Application, By Gender, By End-User) Sweden (By Product) Netherlands (By Product) Switzerland (By Product) Poland (By Product) Ukraine (By Product) Portugal (By Product) Rest of Nordic (By Product) Rest of Europe (By Product)